Insys to cough up $150M to settle Justice Department’s probe into Subsys salesAllbiopro2018-08-09T02:01:06+09:008월 9th, 2018|
Samsung commits billions of dollars to building its biologics businessAllbiopro2018-08-09T02:00:39+09:008월 9th, 2018|
Teva confident in September approval for migraine drug despite latest Celltrion plant citationAllbiopro2018-08-09T02:00:11+09:008월 9th, 2018|
MilliporeSigma’s BioReliance® Product Characterization Services Help Ensure Purity, Safety And EfficacyAllbiopro2018-08-09T01:59:43+09:008월 9th, 2018|
How virus ‘clusters’ cause norovirus and other stomach bugs to spreadAllbiopro2018-08-09T01:59:14+09:008월 9th, 2018|
Drug Pricing Is Important, but the Need for Scientific Innovation is GreaterAllbiopro2018-08-09T01:58:47+09:008월 9th, 2018|
Novo Nordisk U.S. Sales Slump in 2Q and Predicts Continued Decline for 2019Allbiopro2018-08-09T01:58:19+09:008월 9th, 2018|
Regenxbio’s wet AMD gene therapy shows promise in phase 1Allbiopro2018-08-09T01:57:52+09:008월 9th, 2018|
Quick-fire fundraisings give Apexigen $73M for I-O pushAllbiopro2018-08-09T01:57:26+09:008월 9th, 2018|
Boston Scientific Continues M&A Spree with $160 Million Deal for Veniti, Lays Off 85 in MassachusettsAllbiopro2018-08-09T01:56:59+09:008월 9th, 2018|
SQZ raises $72M as cell therapies close in on clinical trialsAllbiopro2018-08-09T01:56:30+09:008월 9th, 2018|
Liver-focused Ambys launches with $140M, Takeda partnershipAllbiopro2018-08-09T01:56:04+09:008월 9th, 2018|
Anti-antibody anybody? Bio-Rad range to target Lucentis biosimilar developersAllbiopro2018-08-09T01:55:37+09:008월 9th, 2018|
Celltrion receives FDA 483 with 8 ‘manageable and correctible’ observationsAllbiopro2018-08-09T01:55:10+09:008월 9th, 2018|
Key aspects of human cell aging reversed by new compoundsAllbiopro2018-08-09T01:53:51+09:008월 9th, 2018|
